We constructed the NAFLD cell model by inducing HepG2 cells with PA to verify the effect of VEGFB gene knockdown on the AMPK/ACC and the AMPK/SREBP1 signaling pathway in hepatocytes. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.